文献速递自身炎症与 IgG4 相关病

未分化复发性发热综合征(SURF)患者的临床特征、长期随访及治疗反应

Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF).
PubMed 文献 · Semin Arthritis Rheum · 2022-05-10

该回顾性研究纳入2008至2021年在一个三级转诊中心随访至少1年的50例未分化复发性发热患者,中位起病年龄3岁,中位随访3.3年。秋水仙碱治疗48例,完全缓解31例(64.6%),部分缓解9例(18%),耐药9例(16.7%);全身性淋巴结肿大及渗出性扁桃体炎与秋水仙碱无反应相关。作者认为SURF应被视为多因素自身炎症性疾病中的独立临床实体。

要点

  • SURF患者基线最常见表现为关节痛(70%)和腹痛(65%)。
  • 秋水仙碱完全缓解率64.6%,部分缓解者年发热发作中位减少72%。
  • 全身性淋巴结肿大及渗出性扁桃体炎与秋水仙碱无反应相关。

核心结论

  • 作者报告了迄今文献中最大系列的未分化复发性发热综合征(SURF)患者。
  • 作者认为SURF应被视为多因素自身炎症性疾病背景下的独立临床实体。

研究设计与样本

  • 回顾性研究,纳入2008至2021年在一个三级转诊中心就诊并随访至少1年的未分化复发性发热患者。
  • 排除单基因复发性发热、携带意义未明变异者及PFAPA综合征患者。
  • 共纳入50例患者(34例男性,16例女性)。

主要发现

  • 中位起病年龄3岁,中位随访3.3年。
  • 基线时关节痛占70%,腹痛占65%,为最常见表现。
  • 按需使用NSAIDs或激素效果不一且短暂。
  • 10例(20%)接受扁桃体切除术,手术无效。
  • 48例(96%)接受秋水仙碱治疗,完全缓解(无发热)31例(64.6%),部分缓解9例(18%),部分缓解者年发热发作中位减少72%,耐药9例(16.7%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe a homogeneous group of patients with undifferentiated recurrent fevers followed-up in a tertiary referral center for systemic autoinflammatory diseases (SAIDs). METHODS: Patients with undifferentiated recurrent fevers seen at our Center from 2008 to 2021 and followed-up for at least one year were included in a retrospective study. Monogenic recurrent fevers, patients carrying variants of unknown origin and PFAPA (Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis) syndrome were excluded. RESULTS: Fifty patients (34 male, 16 female) were included in the study. The median age at onset was 3 years, and the median follow-up was 3.3 years. At baseline, arthralgia (70%) and abdominal pain (65%) were the most frequent manifestations. NSAIDs or steroids on demand had a variable and transient effect. Tonsillectomy was ineffective in the 10 patients (20%) that underwent surgery. Forty-eight patients (96%) were treated with colchicine. A complete response (absence of fever) was achieved in 31 patients (64.6%). Nine patients (18%) showed a partial response, with a median reduction of fever episodes per year of 72%. Nine patients (16.7%) were considered resistant to colchicine. The presence of generalized lymphadenopathy and, to a lesser extent, exudative tonsillitis was associated with a lack of response to colchicine. CONCLUSIONS: We describe the largest series of patients with syndrome of undifferentiated recurrent fever (SURF) reported in the literature so far. SURF should be considered as a distinct clinical entity in the context of multifactorial autoinflammatory diseases.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Sutera D, Bustaffa M, Papa R, et al. Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF). Semin Arthritis Rheum. 2022. PMID: 35598507. doi:10.1016/j.semarthrit.2022.152024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。